Ubtech Robotics: Production Control and Consumer Pivot Tested by Rival IPO and Slowing Economy
02.06.2026 - 01:20:53 | boerse-global.de
The humanoid robotics industry has crossed the threshold from technical feasibility to the brutal business of scaling. For Ubtech Robotics, the answer lies in a dual strategy: buying manufacturing capacity and launching consumer-facing robots, even as a looming competitor IPO and weakening Chinese macro data weigh on its stock.
The Fenglong Gambit: Buying Factory Control
In late April 2026, Ubtech completed the acquisition of a 43.01% stake in Zhejiang Fenglong Electric, a precision manufacturer based in Shenzhen, for approximately 1.665 billion yuan. The deal, structured through direct share transfers and a partial tender offer, gives the Hong Kong-listed company immediate access to 94 million Fenglong shares and established production lines. Ubtech is following a pattern sweeping Chinese robotics: Hangzhou Colin paid 400 million yuan for 51% of Kepler Robotics, and AgiBot took control of Shangwei New Material. But Ubtech’s move is the largest single bet yet on vertical integration.
The logic is compelling. IDC projects over 50,000 humanoid robots will be shipped globally in 2026, with some forecasts hitting 100,000 units. Stable supply chains are a prerequisite for those volumes, and building from scratch takes years. Ubtech opted to buy ready-made capacity.
Stock Under the Knife
The market has not rewarded the strategy. Ubtech shares closed at HK$102.20 on Friday, down 6.92% on the day, accelerated by a block trade of 65,300 shares at HK$104.60. That translates to €11.92 per share in euro terms — 29.7% below the 52-week high of €16.95 set in October 2025. The year-to-date loss stands at 17.82% in Hong Kong dollars. The stock’s 30-day volatility is 56.07%, and the RSI of 44.3 signals neutral territory after dipping to HK$101.20 earlier in the week.
Should investors sell immediately? Or is it worth buying Ubtech Robotics?
Unitree’s IPO Threat
Timing could hardly be more challenging. On June 1, the Shanghai Stock Exchange reviewed the listing application of Unitree Robotics, Ubtech’s archrival. Unitree aims to raise 4.2 billion yuan (US$608 million) on the STAR Market. The company shipped over 5,100 humanoid robots in 2025 and commands a 39% global market share, according to Omdia. Yet its first-quarter 2026 results show cracks: revenue growth collapsed from 332% to 68%, and adjusted net profit plummeted 52.55%. Unitree blames surging R&D and sales costs, a fading hype cycle, and a tough comparison base after the 2025 boom. Most of the IPO proceeds are earmarked for AI model research — a bet on a technological pivot.
A successful listing would set a valuation benchmark for the sector and could redirect investor capital away from Ubtech.
Walker C1: Dancing Into Consumer Markets
Ubtech is fighting back with a new product line. The company unveiled the Walker C1, a full-service robot capable of performing waltz and ballet choreography with human dancers. It targets hotels, airports, and convention centers. The C1 is the first product under the UWORLD consumer brand, announced by founder Zhou Jian on May 20. From June 22, the robot will appear as an official “Silicon Ambassador” at the China International Supply Chain Expo, which draws exhibitors from 85 countries, 36.5% of them from overseas.
To support the C1, Ubtech secured a supply agreement with Far East Smart Energy. Its subsidiary Far East Electric will deliver custom-designed power and signal cables branded ROBOT-ER, rated for over one million cycles under 1,000 g/mm² load, with bending and torsion lifespans exceeding three million cycles.
Operating Momentum vs. Macro Headwinds
While the stock struggles, the operating picture is improving. Full-year 2025 revenue jumped 53.3% to 2.001 billion yuan. Gross margin expanded from 28.7% to 37.7%, and net loss narrowed 31.9% to 790 million yuan. Management forecasts gross margin of 40%-43% for 2026. The humanoid segment exploded from 35.6 million yuan to 821 million yuan — a 23-fold surge. The order backlog stands at roughly 1.4 billion yuan. Cash and equivalents at year-end were 4.9 billion yuan, though operating cash burn remained high at 784.1 million yuan.
Ubtech Robotics at a turning point? This analysis reveals what investors need to know now.
But China’s official manufacturing PMI slid to 50.0 in May from 50.3 in April, and the new orders subindex slipped to 49.9 — a contraction signal that could dampen demand for industrial automation. Ubtech’s business relies heavily on large industrial customers.
Sector Fever and IPO Wave
Despite macro drag, China’s embodied intelligence sector is on fire. Over 50 funding rounds totaling around 20 billion yuan were announced in the first quarter of 2026, up nearly 60% year-on-year. Unitree, Galbot, Agibot, Xinghaitu, and Deep Robotics have all breached the 10-billion-yuan valuation mark. Leju Robotics and DEEP Robotics have filed IPO applications with the ChiNext board in Shenzhen and the STAR Market in Shanghai.
For Ubtech, the coming months will reveal whether its manufacturing-first, consumer-second strategy can outpace the competitive threat from Unitree and the broader sector’s brutal scaling race. The stock’s deep discount to its 52-week high suggests investors are hedging their bets.
Ad
Ubtech Robotics Stock: New Analysis - 2 June
Fresh Ubtech Robotics information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Ubtech Aktien ein!
FĂĽr. Immer. Kostenlos.
